143 related articles for article (PubMed ID: 12806677)
1. [Use and misuse of antibacterial agents in chronic bronchitis].
Brubakk O; Walstad RA
Tidsskr Nor Laegeforen; 2003 May; 123(10):1355-6. PubMed ID: 12806677
[No Abstract] [Full Text] [Related]
2. [Fluoroquinolone superior to macrolide. Longer infection free period after acute bronchitis].
MMW Fortschr Med; 2003 Feb; 145(7):63. PubMed ID: 12652830
[No Abstract] [Full Text] [Related]
3. Antibiotic treatment for patients with acute exacerbations of chronic bronchitis.
Pacios E; Gestoso I; Villarroel P
Clin Microbiol Infect; 2007 Jul; 13(7):747-8. PubMed ID: 17441978
[No Abstract] [Full Text] [Related]
4. The use of moxifloxacin for acute exacerbations of chronic obstructive pulmonary disease and chronic bronchitis.
Wilson R; Macklin-Doherty A
Expert Rev Respir Med; 2012 Nov; 6(5):481-92. PubMed ID: 23113693
[TBL] [Abstract][Full Text] [Related]
5. Conclusions. Role of the oral Beta-lactams in the treatment of exacerbations of chronic bronchitis: critical analysis and therapeutics recommendations.
Blasi F; Concia E; Mazzei T; Moretti AM; Nicoletti G; Novelli A; Tempera G;
J Chemother; 2010 Nov; 22 Suppl 1():25-8. PubMed ID: 21097390
[No Abstract] [Full Text] [Related]
6. [Systemic antibiotherapy for the treatment of lower respiratory tract infections. Community acquired pneumonia, acute exacerbation of obstructive chronic bronchitis].
Chidiac C; ;
Med Mal Infect; 2011 May; 41(5):221-8. PubMed ID: 21106313
[No Abstract] [Full Text] [Related]
7. Short-course therapy of acute bacterial exacerbation of chronic bronchitis: a double-blind, randomized, multicenter comparison of extended-release versus immediate-release clarithromycin.
Nalepa P; Dobryniewska M; Busman T; Notario G
Curr Med Res Opin; 2003; 19(5):411-20. PubMed ID: 13678478
[TBL] [Abstract][Full Text] [Related]
8. [Equally whether the child's lung or chronically inflamed bronchi. Acute bacterial infections have to be terminated fast].
MMW Fortschr Med; 2004 Mar; 146(11):56. PubMed ID: 15152775
[No Abstract] [Full Text] [Related]
9. Short-course fluoroquinolone therapy in exacerbations of chronic bronchitis and COPD.
Anzueto A; Miravitlles M
Respir Med; 2010 Oct; 104(10):1396-403. PubMed ID: 20580215
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological and pharmaeconomic considerations.
Blasi F; Concia E; Mazzei T; Moretti AM; Nicoletti G; Novelli A; Tempera G;
J Chemother; 2010 Nov; 22 Suppl 1():14-24. PubMed ID: 21097389
[No Abstract] [Full Text] [Related]
11. Severe acute exacerbation of chronic obstructive pulmonary disease: when are multiple-drug-resistant bacteria the culprits?
Epstein SK
Crit Care Med; 2006 Dec; 34(12):3047-8. PubMed ID: 17130702
[No Abstract] [Full Text] [Related]
12. Etiology issues and problems of antibiotic resistance.
Blasi F; Concia E; Mazzei T; Moretti AM; Nicoletti G; Novelli A; Tempera G;
J Chemother; 2010 Nov; 22 Suppl 1():8-13. PubMed ID: 21097388
[No Abstract] [Full Text] [Related]
13. The place of antibiotic therapy in the management of chronic acute exacerbations of chronic bronchitis.
Akalin HE
Int J Antimicrob Agents; 2001; 18 Suppl 1():S49-55. PubMed ID: 11574196
[TBL] [Abstract][Full Text] [Related]
14. Role of the oral Beta-lactams in the treatment of exacerbations of chronic bronchitis: critical analysis and therapeutics recommendations.
Blasi F; Concia E; Mazzei T; Moretti AM; Nicoletti G; Novelli A; Tempera G;
J Chemother; 2010 Nov; 22 Suppl 1():3-4. PubMed ID: 21097386
[No Abstract] [Full Text] [Related]
15. [Comparative assessment of fluoroquinolones efficacy in the treatment of patients with infectious exacerbation of chronic obstructive bronchitis].
Iudina LV; Snezhko VI; Rachko IuV
Lik Sprava; 2004; (1):34-7. PubMed ID: 17051710
[TBL] [Abstract][Full Text] [Related]
16. Who should receive antibiotics for exacerbations of chronic bronchitis? A plea for more outcome-based studies.
Niederman MS
Clin Infect Dis; 2004 Oct; 39(7):987-9. PubMed ID: 15472850
[No Abstract] [Full Text] [Related]
17. [Guideline for treatment respiratory infections].
Oberpichler-Schwenk H
Med Monatsschr Pharm; 2009 Dec; 32(12):437. PubMed ID: 20088344
[No Abstract] [Full Text] [Related]
18. The benefits of long-term systemic antimicrobial therapy in chronic obstructive pulmonary disease.
Berim I; Sethi S
Ther Adv Respir Dis; 2011 Jun; 5(3):207-16. PubMed ID: 21378062
[TBL] [Abstract][Full Text] [Related]
19. Acute exacerbations of chronic bronchitis: new developments concerning microbiology and pathophysiology--impact on approaches to risk stratification and therapy.
Sethi S; Murphy TF
Infect Dis Clin North Am; 2004 Dec; 18(4):861-82, ix. PubMed ID: 15555829
[TBL] [Abstract][Full Text] [Related]
20. [COPD and bacterial colonization: therapeutic implications].
Gómez J; Baños V; García Martín E
Rev Esp Quimioter; 2005 Jun; 18(2):187-91. PubMed ID: 16130042
[No Abstract] [Full Text] [Related]
[Next] [New Search]
